Table of Contents

company-logo

Cell Source, Inc., a biotechnology company, develops cell therapy treatments based on the management of immune tolerance. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. Cell Source, Inc. was founded in 2012 and is headquartered in New York, New York.

Cell Source Dividend Announcement

• Cell Source does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cell Source dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cell Source Dividend History

Cell Source Dividend Yield

Cell Source current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cell Source stock? Use our calculator to estimate your expected dividend yield:

Cell Source Financial Ratios

P/E ratio-4.87
PEG ratio-0.05
P/B ratio-1.45
ROE31.36%
Payout ratio-23847630.22%
Current ratio0.02
Quick ratio0.02
Cash Ratio0.01

Cell Source Dividend FAQ

Does Cell Source stock pay dividends?
Cell Source does not currently pay dividends to its shareholders.
Has Cell Source ever paid a dividend?
No, Cell Source has no a history of paying dividends to its shareholders. Cell Source is not known for its dividend payments.
Why doesn't Cell Source pay dividends?
There are several potential reasons why Cell Source would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cell Source ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cell Source has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cell Source a dividend aristocrat?
Cell Source is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cell Source a dividend king?
Cell Source is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cell Source a dividend stock?
No, Cell Source is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cell Source stocks?
To buy Cell Source you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cell Source stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.